CLDX
Celldex Therapeutics·NASDAQ
--
--(--)
--
--(--)
CLDX Filings
Filing Date
Form Description
Form Type
2026-03-26
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-03-26 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-03-10
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-03-10 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-02-25
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Financials
2026-02-25 · Financials
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026-02-25
Form 8-K - Current report
Key Events
2026-02-25 · Key Events
Form 8-K - Current report
2026-02-10
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-02-10 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-02-09
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026-02-09 ·
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026-01-06
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-01-06 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-12-17
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-12-17 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-12-08
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-12-08 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-12-04
Form 144 - Report of proposed sale of securities
Ownership
2025-12-04 · Ownership
Form 144 - Report of proposed sale of securities
